AceLink’s team is composed of professionals with deep understanding and experience in glycolipid biology

AceLink’s team is composed of professionals with deep understanding and experience in glycolipid biology and the intricacies of rare genetic diseases. This specialized knowledge is crucial in identifying and developing novel therapeutic approaches that target the underlying mechanisms of these diseases. The team’s expertise ensures that AceLink remains at the cutting edge of drug development, addressing unmet medical needs in these challenging areas.Central to AceLink’s business model is its collaborative approach. The company partners with a broad network of experienced contract research organizations (CROs), academics, and key opinion leaders (KOLs). This collaborative ecosystem allows AceLink to leverage diverse expertise and resources, facilitating the efficient transformation of scientific discoveries into therapeutic innovations.